OnCo
technologiesTechnologyEstablished

Clinical NGS bioinformatics and variant interpretation

Software that turns raw sequencer output into a report of which mutations matter and which drugs they point to.

Secondary analysis (alignment, variant calling: Illumina DRAGEN, Sentieon, GATK) and tertiary interpretation (Sophia Genetics DDM, QIAGEN QCI Interpret, PierianDx, Velsera/Seven Bridges, Genoox, Congenica) automate clinical reporting against knowledgebases such as OncoKB, CIViC, ClinVar, and COSMIC. Consistency of variant classification (AMP/ASCO/CAP tiers) across labs and the maintenance of curated knowledge are the quality issues; FDA has recognised OncoKB as a source for level-of-evidence claims.

Generic schematic · not to scale · placeholder for the diagnostics front
Molecular read-out

How it works

Pipelines call and annotate variants, apply tumour-normal or panel-of-normals filtering, and match variants to curated evidence tiers to draft clinician reports.

Strengths
  • Standardises interpretation
  • Rapid turnaround
  • Links to trials
Limitations
  • Knowledgebase currency and disagreement
  • Complex variants (fusions, CNVs, MSI/TMB) need tuned pipelines
  • LDT and software-as-medical-device regulation evolving

Latest papers

top
Latest papers · live from Europe PMC
Open in Europe PMC

Query for this technology: (TITLE:"Clinical NGS bioinformatics and variant interpretation" OR ABSTRACT:"Clinical NGS bioinformatics and variant interpretation") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Clinical NGS bioinformatics and variant interpretation, not a curated reading list.

Connected

14top